Search Results - "José Ángel Díaz Arias"
-
1
Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC‐50 Model
Published in HemaSphere (01-08-2022)“…A growing need to evaluate risk‐adapted treatments in multiple myeloma (MM) exists. Several clinical and molecular scores have been developed in the last…”
Get full text
Journal Article -
2
Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns
Published in Frontiers in oncology (15-02-2019)“…Chronic lymphocytic leukemia (CLL) is the most frequent lymphoproliferative syndrome in western countries. CLL evolution is frequently indolent, and treatment…”
Get full text
Journal Article -
3
Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data
Published in Leukemia (01-10-2021)“…Multiple myeloma (MM) remains mostly an incurable disease with a heterogeneous clinical evolution. Despite the availability of several prognostic scores,…”
Get full text
Journal Article -
4
Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
Published in Frontiers in oncology (04-10-2023)Get full text
Journal Article -
5
New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
Published in Frontiers in genetics (20-09-2019)“…Chronic lymphocytic leukemia (CLL) is the most frequent lymphoproliferative syndrome in Western countries, and it is characterized by recurrent large genomic…”
Get full text
Journal Article -
6
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
Published in BMC cancer (21-10-2020)“…Thirty to forty percent of patients with Diffuse Large B-cell Lymphoma (DLBCL) have an adverse clinical evolution. The increased understanding of DLBCL biology…”
Get full text
Journal Article -
7
The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution
Published in BMC cancer (29-05-2019)“…Chronic Lymphocytic Leukemia (CLL) is the most frequent lymphoproliferative disorder in western countries and is characterized by a remarkable clinical…”
Get full text
Journal Article -
8
Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
Published in PloS one (15-09-2022)“…[This corrects the article DOI: 10.1371/journal.pone.0247093.]…”
Get full text
Journal Article -
9
De novo drug design through artificial intelligence: an introduction
Published in Frontiers in hematology (25-01-2024)“…Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global health needs. De novo drug design is a promising strategy to…”
Get full text
Journal Article -
10
Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
Published in Cancers (16-03-2021)“…There is growing evidence indicating the implication of germline variation in cancer predisposition and prognostication. Here, we describe an analysis of…”
Get full text
Journal Article -
11
Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling
Published in Clinical epigenetics (28-03-2024)“…Acute lymphoblastic leukemia (ALL) is the most prevalent cancer in children, and despite considerable progress in treatment outcomes, relapses still pose…”
Get full text
Journal Article -
12
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma
Published in Frontiers in oncology (28-04-2023)“…Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of aggressive lymphoma. Approximately 60% of fit patients achieve curation with…”
Get full text
Journal Article -
13
Prognostic Stratification of Diffuse Large B‐cell Lymphoma Using Clinico‐genomic Models: Validation and Improvement of the LymForest‐25 Model
Published in HemaSphere (01-04-2022)“…Diffuse large B‐cell lymphoma (DLBCL) is the most common type of non‐Hodgkin lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of…”
Get full text
Journal Article -
14
Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
Published in PloS one (01-01-2022)Get full text
Journal Article -
15
Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome
Published in Scientific reports (12-02-2020)“…Mutations in non-coding DNA regions are increasingly recognized as cancer drivers. These mutations can modify gene expression in cis or by inducing high-order…”
Get full text
Journal Article -
16
Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling
Published in Frontiers in oncology (29-03-2021)“…Acute Myeloid Leukemia (AML) is a heterogeneous neoplasm characterized by cytogenetic and molecular alterations that drive patient prognosis. Currently…”
Get full text
Journal Article -
17
Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
Published in Frontiers in oncology (17-08-2022)“…Risk stratification in acute myeloid leukemia (AML) has been extensively improved thanks to the incorporation of recurrent cytogenomic alterations into risk…”
Get full text
Journal Article -
18
Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
Published in Frontiers in oncology (10-01-2022)“…Follicular Lymphoma (FL) has a 10-year mortality rate of 20%, and this is mostly related to lymphoma progression and transformation to higher grades. In the…”
Get full text
Journal Article -
19
A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia
Published in Journal of oncology (2019)“…Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized by its heterogeneous clinical evolution. Despite the discovery of the most…”
Get full text
Journal Article -
20
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes
Published in PloS one (04-05-2021)“…B-cell lymphoproliferative disorders exhibit a diverse spectrum of diagnostic entities with heterogeneous behaviour. Multiple efforts have focused on the…”
Get full text
Journal Article